skip to primary navigationskip to content



  • Brien P, Pugazhendi D, Woodhouse S, Pell JM. 2013 p38α MAPK regulates adult muscle stem cell fate by restricting progenitor proliferation during postnatal growth and repair. Stem Cells In press
  • Woodhouse S, Pugazhendi D, Brien P, Pell JM. 2013 Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation. J Cell Sci 126:565-579


  • Paxton CW, Cosgrove RA, Drozd AC, Wiggins EL, Woodhouse S, Watson RA, Spence HJ, Ozanne BW, Pell JM. 2011 The BTB-Kelch protein Krp1 regulates proliferation and differentiation of myoblasts. Am J Physiol Cell Physiol 300:C1345-55


  • Lovett FA, Cosgrove RA, Gonzalez I, Pell JM. 2010 Essential Role for p38α MAPK but not p38γ MAPK in Igf2 expression and myoblast differentiation. Endocrinology 151:4368-80
  • Smith NN, Kelly MJ, Pell JM, Hill RA 2010 Administration of bovine anti-IGF-I immunoglobulin to dietary protein deficient rats alters dietary intake and plasma IGF-I binding profiles but does not affect change in body mass. Animal 4:1553-1560
  • Stewart CE, Pell JM. 2010 Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Point: IGF is the major physiological regulator of muscle mass. J Appl Physiol. 108:1820-1; discussion 1823-4; author reply 1832


  • Carter EJ, Cosgrove RA, Gonzalez I, Eisemann JH, Lovett FA, Cobb LJ, Pell JM. 2009 MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2. J Cell Sci. 122:3104-12
  • Tripathi G, Salih DA, Drozd AC, Cosgrove RA, Cobb LJ, Pell JM. 2009 IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo. FASEB J. 23:2616-26


  • Hill RA, Flint DJ, Pell JM. 2008 Antibodies as molecular mimics of biomolecules: roles in understanding physiological functions and mechanisms. Adv Physiol Educ. 32:261-73


  • Lovett FA, Gonzalez I, Salih DA, Cobb LJ, Tripathi G, Cosgrove RA, Murrell A, Kilshaw PJ, Pell JM. 2006 Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation. J Cell Sci. 119:4828-40


  • Pell JM, Salih DA, Cobb LJ, Tripathi G, Drozd A. 2005 The role of insulin-like growth factor binding proteins in development. Rev Endocr Metab Disord. 6:189-98
  • Salih DA, Mohan S, Kasukawa Y, Tripathi G, Lovett FA, Anderson NF, Carter EJ, Wergedal JE, Baylink DJ, Pell JM. 2005 Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 146:931-40


  • Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DA, Lovett FA, Holding C, Pell JM. 2004 Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol. 24:3607-22
  • Cobb LJ, Salih DA, Gonzalez I, Tripathi G, Carter EJ, Lovett F, Holding C, Pell JM. 2004 Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J Cell Sci. 117:1737-46
  • Salih DA, Tripathi G, Holding C, Szestak TA, Gonzalez MI, Carter EJ, Cobb LJ, Eisemann JE, Pell JM. 2004 Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci USA 101:4314-9


  • Hollowood AD, Stewart CE, Perks CM, Pell JM, Lai T, Alderson D, Holly JM. 2002 Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF independent actions. J Cell Biochem. 86:583-9
  • O'Sullivan DC, Szestak TA, Pell JM. 2002 Regulation of IGF-I mRNA by GH: putative functions for class 1 and 2 message. Am J Physiol Endocrinol Metab. 283:E251-8
  • O'Sullivan DC, Szestak TA, Pell JM. 2002 Regulation of hepatic insulin-like growth factor I leader exon usage in lambs: effect of immunization against growth hormone-releasing factor and subsequent growth hormone treatment. J Anim Sci. 801074-82


  • Herrler A, Pell JM, Allen WR, Beier HM, Stewart F. 2000 Horse conceptuses secrete insulin-like growth factor-binding protein 3. Biol Reprod. 62:1804-11
  • Pell JM, Hill RA, Stewart CE, Weston CR, Flick-Smith HC. 2000 Enhancement of insulin-like growth factor I activity by novel antisera: potential structure/function interactions. Endocrinology 141:741-51.